1-17 of 17
Authors: Marco Valgimigli
Save search
Sort by
Journal Article

Management of patients with congenital bleeding disorders and cardiac indications for antithrombotic therapy: A clinical consensus statement of the ESC Working Group on Thrombosis, the Association for Acute CardioVascular Care (ACVC), European Association of Percutaneous Cardiovascular Interventions (EAPCI), European Heart Rhythm Association (EHRA) of the ESC, the ESC Working Group on Cardiovascular Pharmacotherapy and the European Association for Haemophilia and Allied Disorders (EAHAD)

PDF
Dan Atar and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 11, Issue 3, May 2025, Pages 275–289, https://doi.org/10.1093/ehjcvp/pvaf006
Published: 26 March 2025
Journal Article

P2Y12 inhibitor monotherapy after short DAPT in acute coronary syndrome: a systematic review and meta-analysis

PDF
Mattia Galli and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 10, Issue 7, November 2024, Pages 588–598, https://doi.org/10.1093/ehjcvp/pvae057
Published: 25 July 2024
Journal Article

External validity of the PRECISE-DAPT score in patients undergoing PCI: a systematic review and meta-analysis

PDF
Andrea Raffaele Munafò and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 9, Issue 8, December 2023, Pages 709–721, https://doi.org/10.1093/ehjcvp/pvad063
Published: 26 August 2023
Journal Article
EDITOR'S CHOICE

Antithrombotic treatment strategies in patients with established coronary atherosclerotic disease

PDF
Marco Valgimigli and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 9, Issue 5, August 2023, Pages 462–496, https://doi.org/10.1093/ehjcvp/pvad032
Published: 29 April 2023
Journal Article
EDITOR'S CHOICE

Within and beyond 12-month efficacy and safety of antithrombotic strategies in patients with established coronary artery disease: two companion network meta-analyses of the 2022 joint clinical consensus statement of the European Association of Percutaneous Cardiovascular Interventions (EAPCI), European Association for Acute CardioVascular Care (ACVC), and European Association of Preventive Cardiology (EAPC)

PDF
Eliano Pio Navarese and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 9, Issue 3, April 2023, Pages 271–290, https://doi.org/10.1093/ehjcvp/pvad016
Published: 03 March 2023
Journal Article

Dual antiplatelet therapy duration after percutaneous coronary intervention in patients with indication to oral anticoagulant therapy. A systematic review and meta-analysis of randomized controlled trials

PDF
Claudio Montalto and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 9, Issue 3, April 2023, Pages 220–230, https://doi.org/10.1093/ehjcvp/pvac065
Published: 25 November 2022
Journal Article

Guided and unguided de-escalation from potent P2Y12 inhibitors among patients with acute coronary syndrome: a meta-analysis

PDF
Anne H Tavenier and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 8, Issue 5, September 2022, Pages 492–502, https://doi.org/10.1093/ehjcvp/pvab068
Published: 30 August 2021
Journal Article

The multiplication of loaves and fishes approach: a critic to double anti-thrombotics or to double number of ischaemic events?

PDF
Giuseppe Gargiulo and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 7, Issue 3, May 2021, Pages e29–e30, https://doi.org/10.1093/ehjcvp/pvaa141
Published: 26 December 2020
Journal Article

Antithrombotic therapy according to baseline bleeding risk in patients with atrial fibrillation undergoing percutaneous coronary intervention: applying the PRECISE-DAPT score in RE-DUAL PCI

PDF
Francesco Costa and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 8, Issue 3, May 2022, Pages 216–226, https://doi.org/10.1093/ehjcvp/pvaa135
Published: 01 December 2020
Journal Article

PRECISE-DAPT score for bleeding risk prediction in patients on dual or single antiplatelet regimens: insights from the GLOBAL LEADERS and GLASSY

PDF
Felice Gragnano and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 8, Issue 1, January 2022, Pages 28–38, https://doi.org/10.1093/ehjcvp/pvaa106
Published: 02 November 2020
Journal Article

Safety and efficacy of double vs. triple antithrombotic therapy in patients with atrial fibrillation with or without acute coronary syndrome undergoing percutaneous coronary intervention: a collaborative meta-analysis of non-vitamin K antagonist oral anticoagulant-based randomized clinical trials

PDF
Giuseppe Gargiulo and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 7, Issue FI1, April 2021, Pages f50–f60, https://doi.org/10.1093/ehjcvp/pvaa116
Published: 29 October 2020
Journal Article

Unravelling the puzzle of antithrombotic therapies for complex percutaneous coronary intervention

PDF
Leonardo De Luca and Marco Valgimigli
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 7, Issue 4, July 2021, Pages 352–359, https://doi.org/10.1093/ehjcvp/pvaa107
Published: 16 September 2020
Journal Article

Choices in antithrombotic management for patients with atrial fibrillation undergoing percutaneous coronary intervention: questions (and answers) in chronological sequence

PDF
Andrea Rubboli and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 7, Issue 1, January 2021, Pages 68–73, https://doi.org/10.1093/ehjcvp/pvaa047
Published: 07 May 2020
Journal Article

Impact of chronic obstructive pulmonary disease and dyspnoea on clinical outcomes in ticagrelor treated patients undergoing percutaneous coronary intervention in the randomized GLOBAL LEADERS trial

PDF
Mariusz Tomaniak and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 6, Issue 4, July 2020, Pages 222–230, https://doi.org/10.1093/ehjcvp/pvz052
Published: 09 December 2019
Journal Article

Association between post-percutaneous coronary intervention bivalirudin infusion and net adverse clinical events: a post hoc analysis of the GLOBAL LEADERS study

PDF
Chun Chin Chang and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 6, Issue 1, January 2020, Pages 22–30, https://doi.org/10.1093/ehjcvp/pvz051
Published: 09 December 2019
Journal Article

Pharmacogenomic polygenic response score predicts ischaemic events and cardiovascular mortality in clopidogrel-treated patients

PDF
Joshua P Lewis and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 6, Issue 4, July 2020, Pages 203–210, https://doi.org/10.1093/ehjcvp/pvz045
Published: 03 September 2019
Journal Article

Influence of intravenous fentanyl compared with morphine on ticagrelor absorption and platelet inhibition in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: rationale and design of the PERSEUS randomized trial

PDF
Sophie Degrauwe and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 5, Issue 3, July 2019, Pages 158–163, https://doi.org/10.1093/ehjcvp/pvy031
Published: 08 August 2018